Letteratura
Selezione bibliografica dalla letteratura internazionale su efficacia e sicurezza degli psicofarmaci in gravidanza e nel postpartum (2007 - 2021)
- Antidepressant exposure during pregnancy and risk of autism in the offspring: meta-review of meta-analyses.
- Lithium exposure during pregnancy and the postpartum period: A systematic review and meta-analysis of safety and efficacy outcomes.
- Antipsychotic use in pregnancy and the risk for congenital malformations.
- Pharmacotherapy for perinatal depression.
- Maternal and infant outcomes associated with lithium use in pregnancy: an internationa collaborative meta-analysis of six cohort studies.
- Lithium use in pregnancy and the risk of cardiac malformations.
- Depression in pregnancy.
- Maternal and fetal outcome following exposure to duloxetine in pregnancy: a cohort study.
- The hidden and forgotten psychiatry: the perinatal psychiatry.
- First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study.
- The changing epidemiology of Ebstein's anomaly and its relationship with maternal mental health conditions: a European registry-based study.
- Reproductive safety of second-generation antipsychotics: current data from the Massachusetts General Hospital National Pregnancy Registry for atypical antipsychotics.
- Anticonvulsant mood stabilizer and lithium use and risk of adverse pregnancy outcomes.
- Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence.
- Maternal anxiety during pregnancy and the association with adverse perinatal outcomes: systematic review and meta-analysis.
- British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum.
- Lithium during pregnancy and after delivery.
- Depression in pregnancy: focus on the safety of antidepressant drugs.
- Suicide during Perinatal Period: Epidemiology, Risk Factors, and Clinical Correlates.
- Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study.
- Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
- Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study.
- First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study.
- Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges.
- Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers..
- Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects.
- Aripiprazolo in gravidanza: una rassegna della letteratura internazionale.
- The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.
- Serotonin reuptake inhibitors and breastfeeding: a systematic review.
- Drug exposure in pregnancy and heart defects.
- The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis.
- Risk factors for depressive symptoms during pregnancy: a systematic review.
- Untreated prenatal maternal depression and the potential risks to offspring: a review.
- Valproic acid monotherapy in pregnancy and major congenital malformations.
- Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.
- A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction.
- Antidepressant use in pregnancy and the risk of cardiac defects.
- Antipsychotic therapy during early and late pregnancy. A systematic review.
- Pregnancy and bipolar disorder: a systematic review.
- Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.
- Bipolar disorder in pregnancy: to treat or not to treat?
- The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review.
- Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview.
- Is the cognitive-behavioural therapy an effective strategy also in the prevention of post partum depression? a critical review.
- Aripiprazole and pregnancy: a case report and literature review.
- Is the exposure to antidepressant drugs in early pregnancy a risk factor for spontaneous abortion? A review of available evidences.
- Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
- Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review.
- Antidepressant drugs and breastfeeding.
- Safety of escitalopram in pregnancy: a case series.
- Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine.